Sl. No.

Title of Project

Funding Agency

Project No & Date

Principal Investigators

Amount Sanctioned

1

Synthesis, Biological Evaluation & QSAR study of some Piperidine analogs, cyclized bioisosteres of glutamic acid derivatives with an aim of designing pharmacophore of glutamic acid antagonist as an antineoplastic agent.

UGC

F. P.S.O. 001/06-07 (ERO), Dated 06.11.2006

Prof. (Dr.) Subrata Sen, Principal, C. P. S

Rs. 85,000.00

2

Protein-Family-based drug design: Targeting angiogenesis for cancer therapy

UGC

F. PSO-003/13-14, Dated 18/03/2014

Mr. Ramesh Chandra Das, Asst. Prof., C. P. S

Rs. 4,40,000.00

3

Synthesis, Biological Evaluation & QSAR study of  N-2-(Pyridinyl sufonyl) glutamic acid amides, hydrazides and its analogs, and N-(Pyrole-2-yl sulfonyl) glutamic acid amides, hydrazides and its analogs as antineoplastic agents.

UGC

P.S.O.001/05-06 (ERO), Dated 21.03.2006

Mr. Koushik Sarker,

Asst. Prof., C. P. S

Rs. 1,00,000.00

4

Synthesis, Biological Evaluation & QSAR study of N-(8-Quinolinoyl   sulfonyl)    glutamic acid amides & hydrazides.

 

UGC

F. P.S.O.020/ 06-07 (ERO). Dated 10.02.07

Mr. Avijit Ghosh,

Asst. Prof., C. P. S.

Rs. 85,000.00

5

Stability study of duloxetine on RP-HPLC and characterization of degraded compounds through retro-synthesis

UGC

F. PSO-002/09-10 (ERO), Dated 08.10.2009

Mr. Tapas Kumar Laha,

Asst. Prof., C. P. S.

Rs. 1,10,000.00

6

Synthesis, biological evaluation & QSAR of N-(p-Ethoxy phenyl sulfonyl) glutamic acid analogs and N-(p-Ethoxy phenyl sulfonyl) piperidine 2,4-dicarboxylic acid analogs as possible anticancer agents.

UGC

PSO-003/09-10(ERO) Dated 08.10.09 

Mr. Suvasish Mishra,

Asst. Prof., C. P. S.

Rs. 88,000.00

7

Metabolism and pharmacokinetics study of few Aryl suphonyl -L-glutamic acid and its analogs.

UGC

F. PSO-1/13-14(ERO), Dated 18/03/2014

Mrs. Madhulita Panda,

Asst. Prof., C. P. S

Rs. 5,00,000.00

8

Synthesis, in vitro and in vivo Anti tumor, Antiangiogenic & Apoptosis enhancement study of few N-(2-Benzo[b]thiophene sulphonyl) Glutamic acid & it’s analogs.

UGC

F. PSO-2/13-14(ERO), Dated 18/03/2014

Mr. Abhijit Saha,

Asst. Prof., C. P. S.

Rs. 4,80,000.00

9

Fragment based design of focused VEGFR-2 and EGFR protein tyrosine kinase inhibitors: Lead generation, synthesis and their pharmacological evaluation as anticancer and antiangiogenic agents.

UGC

 PSO-001/14-15, Dated 03/02/2015

Mr. Gourab Saha,

Lecturer, C. P. S.

Rs. 3,00,000.00

10

Metabolism and pharmacokinetics study of few 2-(Benzene sulphonamido) pantan-1,5-dioic acid; Probable anticancer agents.

UGC

PSO-002/14-15, Dated 03/02/2015

Miss Nilufa Yeasmin, Lecturer, C. P. S.

Rs. 3,50,000.00

11

Determination of anti angiogenic pathway of N-(1,5-bis(2-(4-nitro phenyl) hydrazinyl)-1,5-dioxo pentane-2-yl)-3,4-dimethoxy benzene sulphonamide through cell biology study

UGC

PSO-002/15-16, Dated 02/01/2017

Mrs. Prangya Parimita Panda

Lecturer, C. P. S.

Rs. 1,70,000.00